Physiological and anti-inflammatory roles of dietary fiber and butyrate in intestinal functions

JPEN J Parenter Enteral Nutr. 1999 Sep-Oct;23(5 Suppl):S70-3. doi: 10.1177/014860719902300518.

Abstract

Background: We investigated the effects of pectin, a soluble dietary fiber, on the morphological parameters of the small intestine. In addition, we tested the effects of butyrate enemas on dextran sulfate sodium (DSS)-induced experimental colitis.

Methods: Male Wistar rats were fed an elemental diet containing 2.5% pectin for 14 days, and several parameters were then determined. DSS-induced colitis was evoked by the oral administration of water containing 3% DSS for 10 days. The butyrate enema (3 mL of 100 mmol/L butyrate per day) was begun 7 days before the DSS treatment. Interleukin (IL)-8 secretion in the human intestinal epithelial cell line HT-29 was determined by enzyme-linked immunosorbent assay (ELISA).

Results: Pectin feeding induced a significant increase in the villus height and crypt depth in the small intestine. These effects correlated with a significant increase in plasma enteroglucagon levels. Pretreatment with a butyrate enema significantly blocked the development of DSS-induced experimental colitis. In the in vitro experiment, sodium butyrate dose-dependently inhibited tumor necrosis factor (TNF)-alpha-induced IL-8 secretion in HT-29 cells.

Conclusions: A trophic effect due to dietary fiber was directly observed. The generation of short-chain fatty acids and the induction of enteroglucagon release might play an important role in this process. Butyrate, one of the major metabolites of dietary fiber, exerted a potent anti-inflammatory effect both in vivo and in vitro. Dietary fiber may therefore play important roles in the regulation of normal and pathological conditions in the intestine.

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / metabolism
  • Animals
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use*
  • Anticoagulants / administration & dosage
  • Anticoagulants / antagonists & inhibitors
  • Anticoagulants / therapeutic use*
  • Antidiarrheals / administration & dosage
  • Antidiarrheals / therapeutic use*
  • Butyrates / administration & dosage
  • Butyrates / therapeutic use*
  • Colitis / chemically induced
  • Colitis / drug therapy*
  • Colitis / enzymology
  • Dextran Sulfate / antagonists & inhibitors
  • Dextran Sulfate / toxicity
  • Dietary Fiber / therapeutic use*
  • Enema
  • Humans
  • Interleukin-8 / metabolism
  • Intestine, Small / drug effects
  • Intestine, Small / metabolism
  • Male
  • Pectins / administration & dosage
  • Pectins / therapeutic use*
  • Peroxidase / metabolism
  • Rats
  • Rats, Wistar
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Anti-Inflammatory Agents
  • Anticoagulants
  • Antidiarrheals
  • Butyrates
  • Dietary Fiber
  • Interleukin-8
  • Tumor Necrosis Factor-alpha
  • Pectins
  • Dextran Sulfate
  • Peroxidase